Skip to main content

letter

. 1996 Mar;38(3):475. doi: 10.1136/gut.38.3.475

Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.

P J Neilly, K R Gardiner, B J Rowlands

PMCID: PMC1383087 PMID: 8675108

475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Braegger C. P., Nicholls S., Murch S. H., Stephens S., MacDonald T. T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet. 1992 Jan 11;339(8785):89–91. doi: 10.1016/0140-6736(92)90999-j. [DOI] [PubMed] [Google Scholar]
Gardiner K. R., Halliday M. I., Barclay G. R., Milne L., Brown D., Stephens S., Maxwell R. J., Rowlands B. J. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut. 1995 Jun;36(6):897–901. doi: 10.1136/gut.36.6.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
Neilly P. J., Gardiner K. R., Kirk S. J., Jennings G., Anderson N. H., Elia M., Rowlands B. J. Endotoxaemia and cytokine production in experimental colitis. Br J Surg. 1995 Nov;82(11):1479–1482. doi: 10.1002/bjs.1800821110. [DOI] [PubMed] [Google Scholar]
Neilly P. J., Kirk S. J., Gardiner K. R., Anderson N. H., Rowlands B. J. Manipulation of the L-arginine-nitric oxide pathway in experimental colitis. Br J Surg. 1995 Sep;82(9):1188–1191. doi: 10.1002/bjs.1800820913. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES